176 related articles for article (PubMed ID: 10470150)
1. CK20 gene expression: technical limits for the detection of circulating tumor cells.
Champelovier P; Mongelard F; Seigneurin D
Anticancer Res; 1999; 19(3A):2073-8. PubMed ID: 10470150
[TBL] [Abstract][Full Text] [Related]
2. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
Hampton R; Walker M; Marshall J; Juhl H
Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers.
Lukyanchuk VV; Friess H; Kleeff J; Osinsky SP; Ayuni E; Candinas D; Roggo A
Anticancer Res; 2003; 23(3B):2711-6. PubMed ID: 12894563
[TBL] [Abstract][Full Text] [Related]
6. [CK20 mRNA expression in peripheral blood of patients with gastrointestinal carcinoma and its clinical significance].
Na GW; Li J; He KJ; Li HH; Zhao XN; Li XW; Mi HN
Ai Zheng; 2004 Nov; 23(11):1350-3. PubMed ID: 15522189
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients.
Bustin SA; Gyselman VG; Siddiqi S; Dorudi S
Int J Surg Investig; 2000; 2(1):49-57. PubMed ID: 12774338
[TBL] [Abstract][Full Text] [Related]
8. [Significance of detecting disseminated tumor cells in peripheral blood of gastric and colorectal cancer patients].
Zhang XW; Fan P; Yang HY; Yang L; Chen GY
Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):66-9. PubMed ID: 12678992
[TBL] [Abstract][Full Text] [Related]
9. Quantification of CK20 gene and protein expression in colorectal cancer by RT-PCR and immunohistochemistry reveals inter- and intratumour heterogeneity.
Lassmann S; Bauer M; Soong R; Schreglmann J; Tabiti K; Nährig J; Rüger R; Höfler H; Werner M
J Pathol; 2002 Oct; 198(2):198-206. PubMed ID: 12237879
[TBL] [Abstract][Full Text] [Related]
10. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
Guo B; Luo C; Xun C; Xie J; Wu X; Pu J
Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
[TBL] [Abstract][Full Text] [Related]
11. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes.
Jung R; Petersen K; Krüger W; Wolf M; Wagener C; Zander A; Neumaier M
Br J Cancer; 1999 Nov; 81(5):870-3. PubMed ID: 10555760
[TBL] [Abstract][Full Text] [Related]
12. Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients.
Kawamata H; Uchida D; Nakashiro K; Hino S; Omotehara F; Yoshida H; Sato M
Br J Cancer; 1999 May; 80(3-4):448-52. PubMed ID: 10408852
[TBL] [Abstract][Full Text] [Related]
13. Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes.
Soong R; Beyser K; Basten O; Kalbe A; Rueschoff J; Tabiti K
Clin Cancer Res; 2001 Nov; 7(11):3423-9. PubMed ID: 11705858
[TBL] [Abstract][Full Text] [Related]
14. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
Shen C; Hu L; Xia L; Li Y
Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
[TBL] [Abstract][Full Text] [Related]
15. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.
Gazzaniga P; Gandini O; Giuliani L; Magnanti M; Gradilone A; Silvestri I; Gianni W; Gallucci M; Frati L; Aglianò AM
Clin Cancer Res; 2001 Mar; 7(3):577-83. PubMed ID: 11297251
[TBL] [Abstract][Full Text] [Related]
16. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W
Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661
[TBL] [Abstract][Full Text] [Related]
17. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.
Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M
Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
19. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
20. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
Güdemann CJ; Weitz J; Kienle P; Lacroix J; Wiesel MJ; Soder M; Benner A; Staehler G; Doeberitz MV
J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
